Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Quantifying drivers of antibiotic resistance in humans: a systematic review.

Chatterjee A, Modarai M, Naylor NR, Boyd SE, Atun R, Barlow J, Holmes AH, Johnson A, Robotham JV.

Lancet Infect Dis. 2018 Dec;18(12):e368-e378. doi: 10.1016/S1473-3099(18)30296-2. Epub 2018 Aug 29. Review.

PMID:
30172580
2.

Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study.

Knight GM, Costelloe C, Deeny SR, Moore LSP, Hopkins S, Johnson AP, Robotham JV, Holmes AH.

BMC Med. 2018 Aug 23;16(1):137. doi: 10.1186/s12916-018-1121-8.

3.

Revisiting the winter burden of acute gastroenteritis on hospital beds in England: change in data collection supports analytical method for previously missing values.

Sandmann FG, Jit M, Robotham JV, Deeny SR.

J Hosp Infect. 2018 Sep;100(1):115-117. doi: 10.1016/j.jhin.2018.06.008. Epub 2018 Jun 13. No abstract available.

PMID:
29908252
4.

Prevalence of resistance to antibiotics in children's urinary Escherichia coli isolates estimated using national surveillance data.

Pouwels KB, Robotham JV, McNulty CAM, Muller-Pebody B, Hopkins S.

J Antimicrob Chemother. 2018 Aug 1;73(8):2268-2269. doi: 10.1093/jac/dky159. No abstract available.

PMID:
29726990
5.

Estimating the burden of antimicrobial resistance: a systematic literature review.

Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, Knight GM, Robotham JV.

Antimicrob Resist Infect Control. 2018 Apr 25;7:58. doi: 10.1186/s13756-018-0336-y. eCollection 2018.

6.

Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients.

Sandmann FG, Shallcross L, Adams N, Allen DJ, Coen PG, Jeanes A, Kozlakidis Z, Larkin L, Wurie F, Robotham JV, Jit M, Deeny SR.

Clin Infect Dis. 2018 Aug 16;67(5):693-700. doi: 10.1093/cid/ciy167.

7.

Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions?

Dolk FCK, Pouwels KB, Smith DRM, Robotham JV, Smieszek T.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii2-ii10. doi: 10.1093/jac/dkx504.

PMID:
29490062
8.

Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care.

Smith DRM, Dolk FCK, Pouwels KB, Christie M, Robotham JV, Smieszek T.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii11-ii18. doi: 10.1093/jac/dkx503.

PMID:
29490061
9.

Actual versus 'ideal' antibiotic prescribing for common conditions in English primary care.

Pouwels KB, Dolk FCK, Smith DRM, Robotham JV, Smieszek T.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):19-26. doi: 10.1093/jac/dkx502.

PMID:
29490060
10.

Explaining variation in antibiotic prescribing between general practices in the UK.

Pouwels KB, Dolk FCK, Smith DRM, Smieszek T, Robotham JV.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii27-ii35. doi: 10.1093/jac/dkx501.

PMID:
29490059
11.

Potential for reducing inappropriate antibiotic prescribing in English primary care.

Smieszek T, Pouwels KB, Dolk FCK, Smith DRM, Hopkins S, Sharland M, Hay AD, Moore MV, Robotham JV.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii36-ii43. doi: 10.1093/jac/dkx500.

PMID:
29490058
12.

Understanding the gender gap in antibiotic prescribing: a cross-sectional analysis of English primary care.

Smith DRM, Dolk FCK, Smieszek T, Robotham JV, Pouwels KB.

BMJ Open. 2018 Feb 22;8(2):e020203. doi: 10.1136/bmjopen-2017-020203.

13.

Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association.

Pouwels KB, Freeman R, Muller-Pebody B, Rooney G, Henderson KL, Robotham JV, Smieszek T.

J Antimicrob Chemother. 2018 Jun 1;73(6):1700-1707. doi: 10.1093/jac/dky031.

PMID:
29394363
14.

Intensive care unit (ICU)-acquired bacteraemia and ICU mortality and discharge: addressing time-varying confounding using appropriate methodology.

Pouwels KB, Vansteelandt S, Batra R, Edgeworth JD, Smieszek T, Robotham JV.

J Hosp Infect. 2018 May;99(1):42-47. doi: 10.1016/j.jhin.2017.11.011. Epub 2017 Nov 23.

PMID:
29175434
15.

Seasonality of urinary tract infections in the United Kingdom in different age groups: longitudinal analysis of The Health Improvement Network (THIN).

Rosello A, Pouwels KB, Domenech DE Cell├Ęs M, VAN Kleef E, Hayward AC, Hopkins S, Robotham JV, Smieszek T, Opatowski L, Deeny SR.

Epidemiol Infect. 2018 Jan;146(1):37-45. doi: 10.1017/S095026881700259X. Epub 2017 Nov 23.

PMID:
29168442
16.

Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance.

Atkins KE, Lafferty EI, Deeny SR, Davies NG, Robotham JV, Jit M.

Lancet Infect Dis. 2018 Jun;18(6):e204-e213. doi: 10.1016/S1473-3099(17)30478-4. Epub 2017 Nov 13. Review.

PMID:
29146178
17.

Estimating the opportunity costs of bed-days.

Sandmann FG, Robotham JV, Deeny SR, Edmunds WJ, Jit M.

Health Econ. 2018 Mar;27(3):592-605. doi: 10.1002/hec.3613. Epub 2017 Nov 6.

18.

Addressing the Unknowns of Antimicrobial Resistance: Quantifying and Mapping the Drivers of Burden.

Knight GM, Costelloe C, Murray KA, Robotham JV, Atun R, Holmes AH.

Clin Infect Dis. 2018 Feb 1;66(4):612-616. doi: 10.1093/cid/cix765.

19.

Gambling with antibiotics: a novel approach for exploring antibiotic consumption decision-making.

Naylor NR, Uchegbu I, Chatterjee A, Robotham JV.

Public Health. 2017 Oct;151:146-148. doi: 10.1016/j.puhe.2017.07.012. Epub 2017 Aug 9. No abstract available.

20.

Identification of a common Ara h 3 epitope recognized by both the capture and the detection monoclonal antibodies in an ELISA detection kit.

Zhao L, Zhao L, Zhang B, Robotham JM, Roux KH, Tang H.

PLoS One. 2017 Aug 11;12(8):e0182935. doi: 10.1371/journal.pone.0182935. eCollection 2017.

21.

Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption.

Pouwels KB, Batra R, Patel A, Edgeworth JD, Robotham JV, Smieszek T.

J Glob Antimicrob Resist. 2017 Dec;11:71-74. doi: 10.1016/j.jgar.2017.07.013. Epub 2017 Jul 31.

PMID:
28774863
22.

Measuring distance through dense weighted networks: The case of hospital-associated pathogens.

Donker T, Smieszek T, Henderson KL, Johnson AP, Walker AS, Robotham JV.

PLoS Comput Biol. 2017 Aug 3;13(8):e1005622. doi: 10.1371/journal.pcbi.1005622. eCollection 2017 Aug.

23.

Is antimicrobial stewardship cost-effective? A narrative review of the evidence.

Naylor NR, Zhu N, Hulscher M, Holmes A, Ahmad R, Robotham JV.

Clin Microbiol Infect. 2017 Nov;23(11):806-811. doi: 10.1016/j.cmi.2017.06.011. Epub 2017 Jun 20. Review.

24.

Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11-2015/16.

Sandmann FG, Jit M, Robotham JV, Deeny SR.

J Hosp Infect. 2017 Sep;97(1):79-85. doi: 10.1016/j.jhin.2017.05.015. Epub 2017 May 25.

25.

The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England.

Donker T, Henderson KL, Hopkins KL, Dodgson AR, Thomas S, Crook DW, Peto TEA, Johnson AP, Woodford N, Walker AS, Robotham JV.

BMC Med. 2017 Apr 27;15(1):86. doi: 10.1186/s12916-017-0844-2.

26.

Does appropriate empiric antibiotic therapy modify intensive care unit-acquired Enterobacteriaceae bacteraemia mortality and discharge?

Pouwels KB, Van Kleef E, Vansteelandt S, Batra R, Edgeworth JD, Smieszek T, Robotham JV.

J Hosp Infect. 2017 May;96(1):23-28. doi: 10.1016/j.jhin.2017.03.016. Epub 2017 Mar 16.

PMID:
28434629
27.

A Risk Assessment of Antibiotic Pan-Drug-Resistance in the UK: Bayesian Analysis of an Expert Elicitation Study.

Carter D, Charlett A, Conti S, Robotham JV, Johnson AP, Livermore DM, Fowler T, Sharland M, Hopkins S, Woodford N, Burgess P, Dobra S.

Antibiotics (Basel). 2017 Mar 7;6(1). pii: E9. doi: 10.3390/antibiotics6010009.

28.

Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol.

Naylor NR, Silva S, Kulasabanathan K, Atun R, Zhu N, Knight GM, Robotham J.

Syst Rev. 2016 Nov 8;5(1):187.

29.

Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective.

Otter JA, Burgess P, Davies F, Mookerjee S, Singleton J, Gilchrist M, Parsons D, Brannigan ET, Robotham J, Holmes AH.

Clin Microbiol Infect. 2017 Mar;23(3):188-196. doi: 10.1016/j.cmi.2016.10.005. Epub 2016 Oct 13.

30.

The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.

van Kleef E, Deeny SR, Jit M, Cookson B, Goldenberg SD, Edmunds WJ, Robotham JV.

Vaccine. 2016 Nov 4;34(46):5562-5570. doi: 10.1016/j.vaccine.2016.09.046. Epub 2016 Oct 7.

31.

Isolation demand from carbapenemase-producing Enterobacteriaceae screening strategies based on a West London hospital network.

Vella V, Moore LS, Robotham JV, Davies F, Birgand GJ, Otter JA, Brannigan E, Dyakova E, Knight GM, Mookerjee S, Holmes AH.

J Hosp Infect. 2016 Oct;94(2):118-24. doi: 10.1016/j.jhin.2016.04.011. Epub 2016 Apr 22.

PMID:
27209055
32.

Reconstructing transmission trees for communicable diseases using densely sampled genetic data.

Worby CJ, O'Neill PD, Kypraios T, Robotham JV, De Angelis D, Cartwright EJ, Peacock SJ, Cooper BS.

Ann Appl Stat. 2016 Mar;10(1):395-417. Epub 2016 Mar 25.

33.

More Research Is Needed to Quantify Risks, Benefits, and Cost-Effectiveness of Universal Mupirocin Usage.

Deeny SR, Worby CJ, Tosas Auguet O, Cooper BS, Edgeworth J, Cookson B, Robotham JV.

Clin Infect Dis. 2016 May 1;62(9):1193-4. doi: 10.1093/cid/ciw077. Epub 2016 Feb 21. No abstract available.

PMID:
26908798
34.

Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.

Robotham JV, Deeny SR, Fuller C, Hopkins S, Cookson B, Stone S.

Lancet Infect Dis. 2016 Mar;16(3):348-56. doi: 10.1016/S1473-3099(15)00417-X. Epub 2015 Nov 28.

PMID:
26616206
35.

Quantifying the Burden of Hospital-Acquired Bloodstream Infection in Children in England by Estimating Excess Length of Hospital Stay and Mortality Using a Multistate Analysis of Linked, Routinely Collected Data.

Green N, Johnson AP, Henderson KL, Muller-Pebody B, Thelwall S, Robotham JV, Sharland M, Wolkewitz M, Deeny SR.

J Pediatric Infect Dis Soc. 2015 Dec;4(4):305-12. doi: 10.1093/jpids/piu073. Epub 2014 Jul 22.

PMID:
26582869
36.

Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA.

Deeny SR, Worby CJ, Tosas Auguet O, Cooper BS, Edgeworth J, Cookson B, Robotham JV.

J Antimicrob Chemother. 2015 Dec;70(12):3366-78. doi: 10.1093/jac/dkv249. Epub 2015 Sep 3.

37.

Seasonal changes in the incidence of Escherichia coli bloodstream infection: variation with region and place of onset.

Deeny SR, van Kleef E, Bou-Antoun S, Hope RJ, Robotham JV.

Clin Microbiol Infect. 2015 Oct;21(10):924-9. doi: 10.1016/j.cmi.2015.06.023. Epub 2015 Jun 30.

38.

Screening suspected cases for carbapenemase-producing Enterobacteriaceae, inclusion criteria and demand.

Venanzio V, Gharbi M, Moore LS, Robotham J, Davies F, Brannigan E, Galletly T, Holmes AH.

J Infect. 2015 Oct;71(4):493-5. doi: 10.1016/j.jinf.2015.06.002. Epub 2015 Jun 10. No abstract available.

PMID:
26070742
39.

Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach.

van Kleef E, Green N, Goldenberg SD, Robotham JV, Cookson B, Jit M, Edmunds WJ, Deeny SR.

J Hosp Infect. 2014 Dec;88(4):213-7. doi: 10.1016/j.jhin.2014.08.008. Epub 2014 Sep 18.

PMID:
25441017
40.

How to create a calm and confident mindset.

Robotham J.

Aust Nurs Midwifery J. 2014 Oct;22(4):30. No abstract available.

PMID:
29220137
41.

Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infection.

van Kleef E, Gasparrini A, Guy R, Cookson B, Hope R, Jit M, Robotham JV, Deeny SR, Edmunds WJ.

PLoS One. 2014 Jun 16;9(6):e99860. doi: 10.1371/journal.pone.0099860. eCollection 2014.

42.

Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes.

Wu X, Lee EM, Hammack C, Robotham JM, Basu M, Lang J, Brinton MA, Tang H.

J Virol. 2014 Aug;88(15):8433-44. doi: 10.1128/JVI.00081-14. Epub 2014 May 14.

43.

The national one week prevalence audit of universal meticillin-resistant Staphylococcus aureus (MRSA) admission screening 2012.

Fuller C, Robotham J, Savage J, Hopkins S, Deeny SR, Stone S, Cookson B.

PLoS One. 2013 Sep 12;8(9):e74219. doi: 10.1371/journal.pone.0074219. eCollection 2013.

44.

Targeted versus universal screening and decolonization to reduce healthcare-associated meticillin-resistant Staphylococcus aureus infection.

Deeny SR, Cooper BS, Cookson B, Hopkins S, Robotham JV.

J Hosp Infect. 2013 Sep;85(1):33-44. doi: 10.1016/j.jhin.2013.03.011. Epub 2013 Jul 31.

45.

Modelling the transmission of healthcare associated infections: a systematic review.

van Kleef E, Robotham JV, Jit M, Deeny SR, Edmunds WJ.

BMC Infect Dis. 2013 Jun 28;13:294. doi: 10.1186/1471-2334-13-294. Review.

46.

Estimating the effectiveness of isolation and decolonization measures in reducing transmission of methicillin-resistant Staphylococcus aureus in hospital general wards.

Worby CJ, Jeyaratnam D, Robotham JV, Kypraios T, O'Neill PD, De Angelis D, French G, Cooper BS.

Am J Epidemiol. 2013 Jun 1;177(11):1306-13. doi: 10.1093/aje/kws380. Epub 2013 Apr 16.

47.

A journalist's view of reporting medical tests.

Robotham JC.

Med J Aust. 2012 Sep 17;197(6):327. No abstract available.

PMID:
22994815
48.

Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors.

Nag A, Robotham JM, Tang H.

J Virol. 2012 Dec;86(23):12616-24. doi: 10.1128/JVI.01351-12. Epub 2012 Sep 12.

49.

Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation.

Wu X, Robotham JM, Lee E, Dalton S, Kneteman NM, Gilbert DM, Tang H.

PLoS Pathog. 2012;8(4):e1002617. doi: 10.1371/journal.ppat.1002617. Epub 2012 Apr 5.

50.

Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation.

Robotham JV, Graves N, Cookson BD, Barnett AG, Wilson JA, Edgeworth JD, Batra R, Cuthbertson BH, Cooper BS.

BMJ. 2011 Oct 5;343:d5694. doi: 10.1136/bmj.d5694.

Supplemental Content

Loading ...
Support Center